Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Mangalam Drugs and Organics Annual General Meeting

Mangalam Drugs issued a postal ballot notice seeking approval to re-appoint Praveen Saxena as independent director for a second five-year term. Voting closes 17 June 2026.

Source

BSE filing, NSE: MANGALAM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Mangalam Drugs and Organics Ltd: key numbers

Share price
₹29.11
Market cap
₹46.08 Cr
Revenue (annual)
₹232.1 Cr
Net profit (annual)
₹-44.40 Cr
P/E (TTM)
-1.2×Sector 46.1×
Promoter holding
35.65%+0.00% QoQ
FII holding
0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Mangalam Drugs and Organics Ltd

All →

Other annual general meeting announcements

All →